Article info

Download PDFPDF
CASE REPORT
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant

Authors

  1. Correspondence to Dr Marie Lind-Holst, marie.lind-holst{at}rsyd.dk
View Full Text

Citation

Lind-Holst M, Hartling UB, Christensen AE
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant

Publication history

  • Accepted July 1, 2019
  • First published August 4, 2019.
Online issue publication 
August 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.